If Sandwich built this for the heart, is a 50 mg start kinder to my coronaries?
Kent's first job was coronary, not cultural
Mark the chest-pain brief before the luck story. The compound was built to spare myocardium. That brief still owns the fatal hold.
Through the mid-1980s Pfizer's Sandwich site already knew how to dilate vessels for blood pressure. A second brief asked a narrower question: nitrates lose punch as vessels stop answering nitric oxide. Could you keep cyclic GMP around by blocking the enzyme that chews it, instead of pouring more donor on top?
They named phosphodiesterase type 5. Block it, and a small nitric oxide pulse should last longer in smooth muscle. That sentence is a coronary sentence. The 50 mg diamond in a US tray is a later consequence of that enzyme pick, not a bedroom sketch from 1986.
People remember blushing volunteers. They forget the pathway overlap with nitroglycerin. Stack the two and systemic pressure can fall hard enough to hurt the heart the programme hoped to help. The compound card still opens on that stamp. This page is how the stamp got written.
Four hours of cover against pain that lasts all day
Selective pyrazolopyrimidines were on the Sandwich bench by 1986. UK-92,480 was the lead: IC50 near 3.5 nM on the platelet enzyme, clean enough against PDE1-PDE4 to go forward. Animal work showed vasodilation and a modest antiplatelet tilt. Nomination for development landed in 1989. First human swallows started in 1991.
That is a designed code, not a cupboard find. Simon Campbell's chemists built a named inhibitor. Ian Osterloh ran the early human book. What surprised them was the bed that answered, not the fact that an enzyme blocker had been made on purpose.
Volunteer doses walked up toward 200 mg. Plasma half-life sat near four hours - a poor match for angina that does not clock out at lunch. Flush and headache showed at ordinary vasodilator levels. Colour-vision flicker appeared at 150 mg and above, a PDE6 hint filed and left. None of that yet pointed at a 50 mg ED start.
Swansea scored pain and ECG, then ran out of product
Angina cohorts, including work at Morriston Hospital, measured pressure, ECG, and chest pain. Intercourse was not on the case report form.
Relief stayed thin. A four-hour curve cannot cover a disease that lives in the afternoon and the night. Nitrates already owned the rescue pocket. By mid-1993 the angina brief looked like a close. Ordinary metrics would have killed the code.
The AE table kept a quieter line. Repeat-dose volunteers - up to 75 mg three times daily for ten days - logged flush, headache, dyspepsia, muscle ache. After a few days some men also mentioned erections. The monitors treated that as clutter. The title page still said heart.
Clutter is where most files die. Here the map argued back. PDE5 sits thick in penile smooth muscle. Arousal dumps nitric oxide there. Hold the enzyme that clears the cyclic GMP, and an erection already started can last. The bed that moved was not the coronary bed on the protocol cover.
The AE line paid for a new indication
Men did not walk up and offer the detail. Nurses asked. Direct questions pulled the reports. Shame nearly left the finding as a footnote. Keep that much: early cohorts hid the signal until someone named it.
Pfizer flipped the AE into an efficacy brief. In the early 1990s the oral options for ED were empty. Injections, pellets, vacuum rings, implants - those were the tools. A swallow about an hour before activity was a new pattern, not a louder nitrate. New diaries, new endpoints, clinicians willing to write erectile function in ink.
The new ladder settled at 25, 50, and 100 mg as needed, once in twenty-four hours. Fifty milligrams became the usual first swallow - the diamond this page follows. One hundred milligrams sat above after a thin lower trial. Twenty-five milligrams stayed for age, slow liver, strong CYP3A4 block. That ladder is still the US label. This site's compound page keeps the range. This note locks 50 mg because that is the start Sandwich left when the chest-pain job failed.
The label still opens at 50 mg, not at the souvenir
Launch photos later loved the blue 100 mg shape. The prescribing sentence did not. For most men the first recommended swallow is 50 mg as needed.
Dose-ranging watched scores rise against flush, headache, dyspepsia, and a blocked nose. Fifty milligrams bought a clean step over placebo without parking every man on the loudest peak. That is why the label still starts there. Opening at the ceiling 'to be sure' is folklore. It is not the Sandwich leftover.
Culture and the dose point split. Brand trays still cut a blue diamond. Generics keep the milligram when the dye changes. People name 100 mg when they tell the luck story. Clinicians still write 50 mg on a first script. This desk follows the script.
A 50 mg SERP lock is not a ban on titration. It means the failed angina programme left a start, not a trophy. How to time that start lives on the two-hour fries card. History only needs you to stop treating the ceiling as the origin tablet.
March 1998 licensed a route men would swallow
More than 4,500 men had taken the drug across 21 trials by 1997. Dossiers went to the FDA and the European agency. The US stamp landed 27 March 1998. Europe followed in September. First oral ED drug the FDA cleared.
The headlines were louder than most launches. The clinical win was the route. Men who would not inject would swallow. Prescriptions rose because the format was tolerable, not because erectile failure was new. The 50 mg start made that format ordinary: one tablet, about an hour, as needed.
The same stamp pulled a vascular talk into ordinary rooms. New ED in a man with risk factors is often a coronary warning wearing urology clothes. Penile arteries narrow early. Cardiology still owns the nitrate question before foil opens. Sandwich missed angina as a product and still left cardiology holding the first line.
The nitrate ban is the unpaid angina invoice
Sildenafil holds cyclic GMP up. Organic nitrates push the same cascade from the donor side. Together they can drop pressure into syncope or ischaemia.
Absolute contraindication. Not a spacing trick on the ED label. Nitroglycerin, isosorbide, amyl nitrite - the form does not soften it. A 50 mg start is not a gentler nitrate partner than 100 mg. The load is the problem, not the diamond size.
Any chart that might see emergency GTN needs the PDE5 line in plain ink. Cardiology and urology share one list. The molecule built for angina cannot sit next to the classic angina rescue. That is the irony. It is not a punchline.
Later class members inherited the same hold. Switching agents does not open nitrates. Bedside timing after this history sits on the administration card. History explains why a cheap 50 mg generic still prints the warning so large.
Revatio's 20 mg TID stamp came years later, on another clock
Pulmonary arterial hypertension uses the same enzyme in a different bed. Do not read that schedule as a half 50 mg diamond. PDE5 is thick in pulmonary arteries. Block it and pulmonary pressure can fall; the six-minute walk can stretch.
SUPER-1 ran 20, 40, and 80 mg three times daily for twelve weeks. Walk distance improved on all three arms. The primary walk dose-response was flat. 2005 labels settled on 20 mg TID as Revatio so a lung blister would not be read as a Viagra strip.
Twenty milligrams TID is a steady pulmonary regimen. Fifty milligrams once, as needed, is an ED peak. Not interchangeable. Splitting a 50 mg diamond to invent TID is a homemade product. Swallowing leftover Viagra on a PAH chart is another. How those metres were measured sits in the fasted-clock trial note. Discovery only needs one sentence: one molecule, two labels, two clocks.
The point: Sandwich missed angina and left a 50 mg start
Mark the nitrate. Write 50 mg as the usual first swallow, not a daily lung tablet. Thread the Kent dates. Stop.
1986-1989
Sandwich nominates UK-92,480, a selective PDE5 blocker, for an angina programme.
1991-1993
Human work, including Swansea angina cohorts, shows thin chest-pain benefit and a four-hour half-life.
1992-1994
Repeat-dose volunteers mention erections; the team flips the AE into the new brief.
27 March 1998
FDA clears sildenafil as Viagra for ED at 25, 50, and 100 mg as needed - 50 mg the usual start.
2005
Same molecule, different brand: Revatio 20 mg three times daily for PAH - not a 50 mg stand-in.
The organ was a surprise. The enzyme work was not. Plenty of AE columns go nowhere. This one matched PDE5 density and nitric oxide physiology, so the pivot was a rational bet.
Thin angina numbers did not mean sloppy chemistry. Coronary beds did not move enough to beat existing therapy. Penile beds did. Pulmonary beds later did too. Generics now sell the 50 mg tablet without the 1998 brand tax. The hold did not go generic.
Bring the nitrate list to your own clinician before anyone talks milligrams. This page is a research note, not a fill. The compound range on this site stays 25-100 mg. The essay object is how Kent closed the chest-pain brief and kept a 50 mg diamond as the start that still prints first.
Reader mail
Reader questions on this article
Answered by Dr. Priya Raman, PharmD · Clinical pharmacology & drug safety
Letters about the Kent folder. I answer as a safety pharmacist. Named notes. Not your chart.
Kinder is the wrong word. Origin is not a risk score. I mark your nitrate list first, then whether a flight of stairs already brings chest pain. Sex is modest work. If cardiology has already said that work is unsafe, a PDE5 tablet is a later question. GTN, isosorbide, or poppers with any sildenafil - 25, 50, or 100 mg - is a hard stop. Combined cyclic GMP can drop pressure into a faint or worse. I can teach from a mailed history. Your clinician owns clearance. A fair pre-visit read sits at the AHA.
UK-92480 versus UK-92,480 - two molecules or one hyphen fight?
One code. Sandwich wrote UK-92,480. Later write-ups drop the comma. It is sildenafil citrate, the salt that became Viagra. No second drug hides in the punctuation. A blog that treats the spellings as two compounds is not a source.
Did shame really bury the erection reports until nurses asked?
The pattern is solid enough: early repeat-dose cohorts did not offer the detail until staff named it. I will not certify a specific 1992 joke from a day-room. The safety lesson is simpler. I only see what you report. Unexpected effects - even private ones - belong in the room. Here they redefined the indication. In clinic they more often redefine a dose or a hold.
Viagra and Revatio - is my 50 mg diamond just a louder lung tablet?
No. Same salt, incompatible clocks. ED generics: 25-100 mg once in twenty-four hours, about an hour before sex, 50 mg the usual start. Revatio: 20 mg three times daily for pulmonary arterial hypertension, specialist-owned, steady. Brands exist so a pharmacy does not hand a lung blister as an ED diamond. Neither is 'stronger.' Do not snap a 50 mg tablet to invent TID. MedlinePlus keeps the two patient pages apart at MedlinePlus.
If arousal has to come first, what does a 50 mg tablet do on an empty sofa?
Almost nothing useful. Nitric oxide has to land before PDE5 blockade has substrate. No stimulation, no cyclic GMP to hold. Swallow with lead time, then engage. Watching a clock alone manufactures a false failure and a request for a second tablet the same night - which the label forbids. Mechanics first. Escalation later, if ever.
Dad keeps GTN in his jacket and asked me to pick up generic 50 mg. Do I?
No. Intermittent spray is still a nitrate. PDE5 plus nitrate is a hard stop - potentially fatal hypotension, not a family-risk guess. His rescue plan wins. If ED bothers him, cardiology reviews every vasodilator before anyone talks alternatives. Do not buy him a diamond off a cart. That is the original Sandwich hold, not caution theatre.
Does 'accidental' mean the 50 mg tablet rests on thin science?
The tissue was a surprise. The enzyme work was not. Selective PDE5 inhibition, then 21 ED trials and more than 4,500 exposed men before the 1998 stamp. Serendipity in the bed, ordinary development after. I trust a fat trial package more than a thin origin story. This file has the package.
Compound page says 25-100 mg. This essay locks 50. Which do I ask for?
Ask for a clinician's start. Most labels still open at 50 mg. Twenty-five milligrams is the sensitivity rung - age, liver, strong CYP3A4 inhibitors. One hundred milligrams is the ceiling after fair lower trials, not a Sandwich souvenir. This essay locks 50 mg because that is the start the failed angina brief left as the practical first swallow. The range stays on the compound card.
If my generic 50 mg is the same salt, why keep teaching the brand story?
The milligram and the hold transferred. The brand tax did not. I still teach Sandwich because people treat a cheap diamond like a vitamin. Same CYP3A4, same food delay, same nitrate stamp. History is how you remember why a bargain tablet can still drop pressure when GTN sits in the other pocket. FDA labeling stays the source of record at the FDA.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated